An international collaboration led by the University of Gothenburg report that cerebrospinal fluid biomarkers associated with Alzheimer’s pathology—specifically β-amyloid and tau proteins—are also present in individuals diagnosed with other forms of dementia. Associations with cognitive performance were primarily observed in Alzheimer-related diagnoses.
This article was originally published on MedicalXpress.com